Lv7
4280 积分 2021-10-17 加入
Discovery of an LSD1 PROTAC degrader
14天前
已完结
Strategies to Address Low Drug Solubility in Discovery and Development
1个月前
已完结
Harnessing the SPOP E3 Ubiquitin Ligase via a Bridged Proteolysis Targeting Chimera (PROTAC) Strategy for Targeted Protein Degradation
2个月前
已完结
Innovative, combinatorial and high-throughput approaches to degrader synthesis
2个月前
已完结
Identification of a Primary Target of Thalidomide Teratogenicity
2个月前
已完结
Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling
2个月前
已完结
What Is the Right Dose? The Elusive Optimal Biologic Dose in Phase I Clinical Trials
2个月前
已完结
Impact of linker length on the activity of PROTACs
2个月前
已完结
Target and tissue selectivity of PROTAC degraders
4个月前
已完结
CDK4 and CDK6 kinases: From basic science to cancer therapy
4个月前
已完结
皖公网安备34019202002308
